Modulo Bio, Inc. Press Releases

• Published on June 3, 2025 - 12:00 GMT

  

  Modulo Bio Appoints Biotechnology Veteran Joseph Wagner, Ph.D., as Chief Development Officer

  Industry leader brings 25+ years of experience in therapeutic development and precision medicine to advance company's neurodegenerative disease programs SAN DIEGO, CA, UNITED STATES, June 3, 2025 /⁨EINPresswire.com⁩/ -- Modulo Bio, a biotechnology …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on March 19, 2025 - 11:00 GMT

  

  Modulo Bio Announces $4.8M Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF)

  Funds will help support the development of MOD 001, a neuroimmune system modulator SAN DIEGO, CA, UNITED STATES, March 19, 2025 /⁨EINPresswire.com⁩/ -- Modulo Bio, a company reprogramming the brain's immune system, announced today that it has received …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on February 7, 2025 - 13:00 GMT

  

  Modulo Bio Awarded $500,000 Grant from the ALS Association to Advance Novel Therapeutic

  Funds will support IND enabling activities paving the way for clinical trials in ALS and Frontotemporal Dementia SAN DIEGO, CA, UNITED STATES, February 7, 2025 /⁨EINPresswire.com⁩/ -- Modulo Bio announced today that it has received a $500,000 research …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...